Cargando…
Anaplastic astrocytoma cells not detectable on autopsy following long-term temozolomide treatment: A case report
We herein present an autopsy case of a glioma patient who received long-term treatment with temozolomide (TMZ). The patient, a 35-year-old man with a hypointense tumor of the left frontal lobe, without contrast enhancement following gadolinium (Gd) administration on T1-weighted images, underwent tum...
Autores principales: | Hirano, Hirofumi, Kawahara, Takashi, Niiro, Masaki, Yonezawa, Hajime, Takajyou, Tomoko, Ohi, Yasuyo, Kitazono, Ikumi, Sakae, Kiyohiro, Arita, Kazunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403526/ https://www.ncbi.nlm.nih.gov/pubmed/28451406 http://dx.doi.org/10.3892/mco.2017.1160 |
Ejemplares similares
-
Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma
por: Fujimaki, Takamitsu, et al.
Publicado: (2007) -
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013) -
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
por: Khaddour, Karam, et al.
Publicado: (2020) -
Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma
por: Sarica, Feyzi Birol, et al.
Publicado: (2012) -
Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
por: Shinsato, Yoshinari, et al.
Publicado: (2013)